IPRAGLIFLOZIN
UNII 3N2N8OOR7X

Substance Identification & Data

This profile provides standardized clinical and technical data for Ipragliflozin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3N2N8OOR7X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 761423-87-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3N2N8OOR7X

CAS Registry Number

761423-87-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IPRAGLIFLOZIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H21FO5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AHFWIQIYAXSLBA-RQXATKFSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C166685

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

10453870

Unique identification number in the NCBI database of chemical substances.

INN ID

9258

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H]1(O[C@H]([C@@H]([C@H]([C@@H]1O)O)O)c2ccc(c(c2)Cc3sc4c(c3)cccc4)F)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ipragliflozin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.